Dextrins may increase circulating GLP-1 concentrations and satiety in adults with limited evidence certainty
Specific dietary fibers may support GLP-1 levels in adults
This scoping review of 52 studies involving 1,085 participants examined the effects of specific dietary fibers on GLP-1 levels and satiety. …
Certain types of dietary fiber, like dextrins, show promise in increasing GLP-1 levels and helping people feel full.
Evaluating the Efficacy of GLP-1 Receptor Agonists in Patients with Parkinson's Disease
GLP-1 medications show no motor benefit for Parkinson's patients
A meta-analysis reveals that GLP-1 receptor agonists provide no significant motor or non-motor benefits for patients with idiopathic Parkins…
New data suggests GLP-1 receptor agonists do not improve movement or non-motor symptoms in people with Parkinson's disease.
Oral small-molecule GLP-1RAs reduce body weight by 3.93 and HbA1c by 0.94
Oral GLP-1 medications help manage weight and blood sugar
This meta-analysis evaluates the efficacy and safety of oral small-molecule GLP-1RAs in adults with Type 2 Diabetes and obesity. The analysi…
New data shows oral versions of GLP-1 drugs can lower body weight and blood sugar for people with type 2 diabetes or obesity.
Gut microbiota may influence metabolic response to GLP-1 receptor agonists in obesity and type 2 diabetes
Gut bacteria may influence how people respond to weight loss drugs
This narrative review explores how gut microbial communities and metabolite profiles potentially determine patient responses to GLP-1 recept…
New research suggests that the unique makeup of your gut bacteria could play a role in how well you respond to GLP-1 medications.
GLP-1 receptor agonists combined with metformin most effectively reduce weight and BMI in PCOS
GLP-1 Combined With Metformin Shows Weight Loss For PCOS
This network meta-analysis evaluated GLP-1 receptor agonists, metformin, and myoinositol for managing polycystic ovary syndrome. The study f…
A combination of GLP-1 receptor agonists and metformin may be more effective for weight loss in women with polycystic ovary syndrome than ot…
GLP-1 receptor agonists improve motor function and mood outcomes in patients with Parkinson's disease
GLP-1 medications show promise for Parkinson's disease motor symptoms
This meta-analysis of 850 patients found that GLP-1 receptor agonists significantly improved motor function (SMD -0.21 to -0.32) and mood ou…
New data suggests certain GLP-1 medications may improve movement and mood in people living with Parkinson's disease.
GLP-1 receptor agonists are associated with a 3.587 risk ratio for hair loss in obese patients
Weight loss medications linked to higher risk of hair loss
This meta-analysis of interventional studies involving 4114 GLP-1 RA users found a significantly higher risk of hair loss compared to placeb…
New data shows people taking certain weight loss drugs may face a significantly higher risk of losing their hair.
General medical management improves medication adherence and lifestyle outcomes in older adults with type 2 diabetes
New management model improves medication use and health for seniors
This randomized controlled trial of 200 older adults with type 2 diabetes and atherosclerotic cardiovascular disease found that a general me…
A new personalized care plan helps older adults with diabetes and heart disease stay on their medications and improve their daily habits.
Elecoglipron results in 40.4% to 88.8% of patients reaching at least 5% weight loss
Trial shows weight loss in adults with obesity using elecoglipron
This Phase 2 randomized controlled trial evaluated elecoglipron in 310 adults with obesity or overweight and a weight-related condition. Par…
A new clinical trial shows that the medication elecoglipron helps people with obesity lose a significant amount of body weight.
GLP-1R exposure shows no causal link to most mental disorders except eating disorders
GLP-1 Receptor Agonists Show Mixed Links to Mental Health
This meta-analysis investigated the causal associations between GLP-1 receptor agonists and various mental health outcomes including anxiety…
New research explores how GLP-1 receptor agonists relate to conditions like anxiety and depression, finding no clear genetic link to most di…
Multi-target therapies may address combined hypertension and dyslipidemia pathophysiology
Multi-Target Therapies May Address Combined Hypertension and High Cholesterol
This systematic review synthesizes evidence on synergistic mechanisms of hypertension and dyslipidemia, highlighting the RAAS/PPAR axis, AMP…
Combining treatments like statins and RAAS inhibitors may offer a more precise way to manage both high blood pressure and cholesterol levels…
GLP-1 receptor agonists may reduce cognitive decline in type 2 diabetes patients with dementia
GLP-1 drugs may slow cognitive decline in type 2 diabetes
A systematic review of systematic reviews and meta-analyses found that GLP-1 receptor agonists are associated with reduced overall cognitive…
A review of reviews suggests GLP-1 drugs like Ozempic may help protect memory and thinking in people with type 2 diabetes.